Flammer Martina M.D.'s Form 4 filing
INSMED Inc (INSM) · filed Aug 7, 2026
- Accession no.
- 0001796960-26-000020
- Filed
- Aug 7, 2026, 4:39 PM ET
- Trade date
- Aug 6, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.49M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Flammer Martina M.D.CIK 0001796960 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | MOption exerciseAcquired | +18,278 | $18.95 | +$346,368.1 | 78,764 | Direct | |
| Aug 6, 2026 | Common Stock | MOption exerciseAcquired | +8,895 | $25.83 | +$229,757.85 | 87,659 | Direct | |
| Aug 6, 2026 | Common Stock | SSaleDisposed | −8,895 | $127.00 | −$1,129,665 | 78,764 | Direct | |
| Aug 6, 2026 | Common Stock | SSaleDisposed | −18,278 | $129.40F2 | −$2,365,173.2 | 60,486 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | MOption exerciseDisposed | −18,278 | $0.00 | $0 | 36,555 | Direct | |
| Aug 6, 2026 | Common Stock | MOption exerciseDisposed | −8,895 | $0.00 | $0 | 35,580 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 18,278 shares sold at prices ranging from $129.40 to $129.41 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.